Clinical research, an empirical work on the European market of human experimentation
- 96 Downloads
The target of this work is to support the thesis that pharmaceutical companies’ testing phase would be treated like any other form of production in a globalization process, that is to say, a specific phase of pharmaceutical research and development (R&D) could be localized where the cost of clinical evidence is lower.
Subject and methods
Considering Europe, an empirical analysis in order to support the main hypothesis is performed. Taking trials of phases II and III, funded by Industry (dependent variable) and the main macroeconomic features (independent variables) of each nation into account, the empirical work is implemented via regression analysis on panel data (2000–2007). The sample analyzed considers EU-27 plus the candidate states—Croatia, the Former Yugoslav Republic of Macedonia, Turkey—as well as Norway, Switzerland and Iceland.
Results suggest the appropriateness of this process since clinical research is clearly affected by economic conditions, regardless of the scientific purpose.
The conclusions regard the policy maker’s point of view, that is to say, how national competitiveness could be increased on the European market of human experimentation.
KeywordsPharmaceutical company R&D Human experimentation Medical researcher Research subject
Conflict of interest
The author declares that he has no conflict of interest.
- Appelbaum PS, Roth LH, Lidz C (1982) The therapeutic misconception: informed consent in psychiatric research. IJLP 5:319–329Google Scholar
- Appelbaum PS, Roth LH, Lidz C, Benson P, Winslade W (1987) False hope and best data: consent to research and the therapeutic misconception. Hasting Cent Rep 17(2):20–24Google Scholar
- Ariely D (2008) Predictably irrational: the hidden forces that shape our decisions, 1st edn. Harper Collins, LondonGoogle Scholar
- Arrow KJ (1963) Uncertainty and the welfare economics of medical care. AER III(5):941–973Google Scholar
- Blumenthal JA (2004) Law and emotions: the problem of affective forecasting. Indiana Law J 80:155–238Google Scholar
- Calabresi G (1969) Reflection on medical experimentation in humans. Daedalus 98(2):387–405Google Scholar
- Daugherty CK (1999) Impact of therapeutic research on informed consent and the ethics of clinical trials: a medical oncology perspective. JCO 17(5):1601–1617Google Scholar
- Emanuel EJ (1995) A phase I trial on the ethics of phase I trials. JCO 13(5):1049–1051Google Scholar
- Faden RR, Beauchamp TL, King NMP (1986) A history and theory of informed consent. Oxford University Press, New YorkGoogle Scholar
- Green WH (2003) Econometric analysis, 5th edn. New York University, Prentice Hall, New YorkGoogle Scholar
- Ippoliti R (2010) The market of human experimentation. Eur J Law Econ. doi: 10.1007/s10657-010-9190
- Suits DB (1957) Use of dummy variables in regression equations. JASA 52(280):548–551Google Scholar